Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Shrayer

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Melanoma Research|May 1, 1992
Induction of interleukin-2, natural killer cell activity and anti-melanoma antibodies resulting from immunization of mice with formalinized extracellular antigens (FECA) of murine melanomaD Shrayer, J Koness, A Maizel, et al.
Cancer Immunology, Immunotherapy : CII|May 1, 1995
Further characterization of a clinically relevant model of melanoma metastasis and an effective vaccineD Shrayer, H Bogaars, V J Hearing, et al.
The Journal of Dermatology|November 1, 1994
Novel experimental approaches to melanoma diagnosis and therapyV J Hearing, D M Gersten, D Shrayer, et al.
Journal of Surgical Oncology|September 1, 1994
Nude mouse model to study passive humoral immunotherapy directed against B16 F10 murine melanomaD Shrayer, H Bogaars, D Gersten, et al.
Pigment Cell Research|September 1, 1992
B700 antigen as a component of an antimelanoma vaccine: formalinized extracellular antigensD Shrayer, D M Gersten, J Koness, et al.
Archives of Surgery (Chicago, Ill. : 1960)|May 23, 1998
Wound-induced tumor progression: a probable role in recurrence after tumor resectionS O Hofer, D Shrayer, J S Reichner, et al.
International Journal of Oncology|May 14, 2011
Antitumor effects of polyvalent and monovalent vaccines coupled with interleukin-2 in a metastatic melanoma modelD Shrayer, J Koness, N Kouttab, et al.
International Journal of Cancer|February 20, 1993
Generation of cytotoxic antibodies to the B16 murine melanoma using a formalinized vaccineD Shrayer, N Kouttab, A Maizel, et al.
International Journal of Oncology|May 5, 2011
Intrasplenic vaccination against experimental melanomaD Shrayer, C Park, N Kouttab, et al.
Journal of Surgical Oncology|March 1, 1993
Preimmunization of mice with formalinized extracellular antigens of melanoma in combination with IL-2 and surgical resection increased survival and tumor control in metastatic melanoma modelD Shrayer, J Koness, N Kouttab, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Melanoma Research|May 1, 1992
Induction of interleukin-2, natural killer cell activity and anti-melanoma antibodies resulting from immunization of mice with formalinized extracellular antigens (FECA) of murine melanomaD Shrayer, J Koness, A Maizel, et al.
Cancer Immunology, Immunotherapy : CII|May 1, 1995
Further characterization of a clinically relevant model of melanoma metastasis and an effective vaccineD Shrayer, H Bogaars, V J Hearing, et al.
The Journal of Dermatology|November 1, 1994
Novel experimental approaches to melanoma diagnosis and therapyV J Hearing, D M Gersten, D Shrayer, et al.
Journal of Surgical Oncology|September 1, 1994
Nude mouse model to study passive humoral immunotherapy directed against B16 F10 murine melanomaD Shrayer, H Bogaars, D Gersten, et al.
Pigment Cell Research|September 1, 1992
B700 antigen as a component of an antimelanoma vaccine: formalinized extracellular antigensD Shrayer, D M Gersten, J Koness, et al.
Archives of Surgery (Chicago, Ill. : 1960)|May 23, 1998
Wound-induced tumor progression: a probable role in recurrence after tumor resectionS O Hofer, D Shrayer, J S Reichner, et al.
International Journal of Oncology|May 14, 2011
Antitumor effects of polyvalent and monovalent vaccines coupled with interleukin-2 in a metastatic melanoma modelD Shrayer, J Koness, N Kouttab, et al.
International Journal of Cancer|February 20, 1993
Generation of cytotoxic antibodies to the B16 murine melanoma using a formalinized vaccineD Shrayer, N Kouttab, A Maizel, et al.
International Journal of Oncology|May 5, 2011
Intrasplenic vaccination against experimental melanomaD Shrayer, C Park, N Kouttab, et al.
Journal of Surgical Oncology|March 1, 1993
Preimmunization of mice with formalinized extracellular antigens of melanoma in combination with IL-2 and surgical resection increased survival and tumor control in metastatic melanoma modelD Shrayer, J Koness, N Kouttab, et al.
Pageof 1